566 related articles for article (PubMed ID: 33897885)
21. miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process.
Wang H; Shi X; Wu S
Mol Cell Biochem; 2020 Sep; 472(1-2):115-123. PubMed ID: 32567032
[TBL] [Abstract][Full Text] [Related]
22. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
[No Abstract] [Full Text] [Related]
23. MicroRNA‑21 regulates the biological behavior of esophageal squamous cell carcinoma by targeting RASA1.
Chen X; Cai S; Li B; Zhang X; Li W; Liang H; Cao X; Wang L; Wu Z
Oncol Rep; 2019 Mar; 41(3):1627-1637. PubMed ID: 30569149
[TBL] [Abstract][Full Text] [Related]
24. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
Wu Y; Yang Y; Xian YS
Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
[TBL] [Abstract][Full Text] [Related]
25. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
[TBL] [Abstract][Full Text] [Related]
26. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
28. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
[TBL] [Abstract][Full Text] [Related]
29. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
30. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S
J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037
[TBL] [Abstract][Full Text] [Related]
31. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
[TBL] [Abstract][Full Text] [Related]
32. The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.
Min S; Xiaoyan X; Fanghui P; Yamei W; Xiaoli Y; Feng W
Cancer Gene Ther; 2013 Jul; 20(7):379-85. PubMed ID: 23788111
[TBL] [Abstract][Full Text] [Related]
33. CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma.
Wang G; Tang J; Zhan W; Zhang R; Zhang M; Liao D; Wang X; Wu Y; Kang T
Theranostics; 2017; 7(14):3478-3488. PubMed ID: 28912889
[TBL] [Abstract][Full Text] [Related]
34. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Qiu F; Liu L; Lin Y; Yang Z; Qiu F
Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
[TBL] [Abstract][Full Text] [Related]
35. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
[TBL] [Abstract][Full Text] [Related]
38. WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway.
Feng Y; Ma Z; Pan M; Xu L; Feng J; Zhang Y; Shao C; Guo K; Duan H; Zhang Y; Zhang Y; Zhang J; Lu D; Ren X; Han J; Li X; Yan X
Cell Death Dis; 2022 May; 13(5):480. PubMed ID: 35595735
[TBL] [Abstract][Full Text] [Related]
39. RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma.
Yang Q; Lin W; Liu Z; Zhu J; Huang N; Cui Z; Han Z; Pan Q; Goel A; Sun F
Cell Death Dis; 2018 Feb; 9(2):146. PubMed ID: 29396516
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.
Ma T; Zhao Y; Lu Q; Lu Y; Liu Z; Xue T; Shao Y
Biomed Pharmacother; 2018 Feb; 98():680-686. PubMed ID: 29304493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]